~~<i id='76BFAABC06'><strike id='76BFAABC06'><tt id='76BFAABC06'><pre id='76BFAABC06'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

explore

author：Wikipedia 2025-09-30 16:23:07 - browse：93372

A device component from Paradromics Inc., one of the main brain-computer interface players racing to get to market. Courtesy Paradromics Inc.

Rodney Gorham loves fast, flashy cars: His WhatsApp profile picture is a bright yellow Corvette Stingray. “I don’t get to drive it anymore,” Gorham told STAT in a text.

Gorham, a 63-year-old living in Australia, has amyotrophic lateral sclerosis. He can’t speak, and can move his hands and legs only a little. But he is able to control his computer with his thoughts, aided by a brain-computer interface developed by the startup Synchron.

“It has been exciting to be involved,” Gorham wrote.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Doctors on social media are being harassed and cyberbullied

hotspot

explore

focus

AdobeTheFDAhastakenabigstepinencouragingdrugcompaniestoincludepregnantwomeninclinicaltrials,issuinga

WSS

The pain doctors face in trying to build their families

Living with Hashimoto's and celiac disease, and med school, too

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

Tome Biosciences co

Patient advocates sound warning on FDA proposal on salt intake

Bernie Sanders gets little from pharma CEOs on drug prices

focus

explore

hotspot

Apple is now the first public company to be valued at $3 trillion

Patient advocates sound warning on FDA proposal on salt intake

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Clinical trials must include more disabled people

Medical leaders decry Supreme Court decision on affirmative action

Long Covid research funding gets a major boost from NIH

Drug repurposing or repositioning? The language matters

ACIP vaccine advisory panel sees its vacancies filled

Wildfire smoke exposes gaps in outdoor worker protections

Artificial intelligence use in health care faces greater scrutiny in 2024

hotspot

Majority of Americans think Trump's Ga. election interference case is serious: POLL

Why Eli Lilly’s earnings didn’t quite live up to the hype

Patient advocates sound warning on FDA proposal on salt intake

FDA approves first treatment for ultra

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

Listen: Racing for gene therapy & a pioneering approval

explore

focus

focus

focus